Rockefeller Capital Management
TNXP icon

Rockefeller Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Rockefeller Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.09K Buy
370
+330
+825% +$5.08K ﹤0.01% 4235
2025
Q4 		$625 Buy
40
+14
+54% +$258 ﹤0.01% 4506
2025
Q3 		$628 Buy
+26
New +$965 ﹤0.01% 4241

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rockefeller Capital Management's TNXP Position: Q1 2026 in Review

Rockefeller Capital Management increased its Tonix Pharmaceuticals (TNXP) stake by 825% in Q1 2026, buying an estimated $5.08K and bringing the position to 370 shares worth $5.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4235.

Rockefeller Capital Management first reported a position in TNXP in Q3 2025 and has held it in 3 quarters since. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Rockefeller Capital Management held 370 shares of Tonix Pharmaceuticals worth $5.09K as of Q1 2026.
  • Rockefeller Capital Management bought 330 Tonix Pharmaceuticals shares in Q1 2026, an estimated $5.08K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4235 holding.
  • Rockefeller Capital Management first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.